article thumbnail

Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials

Frost & Sullivan

Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes LabCorp’s drug development business, Covance, with the 2020 Global CRO Company of the Year Award. billion in 2019. LabCorp reported revenue of more than $11.5

article thumbnail

Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology

Frost & Sullivan

Based on its recent analysis of the North American contract research organization (CRO) market in dermatology, Frost & Sullivan recognizes TergusPharma (Tergus) with the 2020 North America Customer Value Leadership Award.

Biotech 69
article thumbnail

Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Frost & Sullivan

Innovating for Growth: The Future of Biotech CROs The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. What are the top three trends you see driving change? Yvonne Lungershausen: Thank you, Unmesh.

Biotech 52